IRIS  Catalogo Istituzionale della Ricerca dell'Università degli Studi del Molise

RINALDI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.506
EU - Europa 7.073
AS - Asia 3.320
SA - Sud America 1.072
AF - Africa 489
Continente sconosciuto - Info sul continente non disponibili 56
OC - Oceania 7
Totale 20.523
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.207
RU - Federazione Russa 5.476
SG - Singapore 1.532
BR - Brasile 810
CN - Cina 504
FR - Francia 371
IT - Italia 363
CI - Costa d'Avorio 339
VN - Vietnam 323
DE - Germania 276
BD - Bangladesh 198
HK - Hong Kong 195
IN - India 142
CA - Canada 140
GB - Regno Unito 138
AR - Argentina 90
MX - Messico 77
PL - Polonia 70
NL - Olanda 68
IQ - Iraq 58
ZA - Sudafrica 55
TR - Turchia 47
ID - Indonesia 41
JP - Giappone 40
CO - Colombia 38
ES - Italia 38
EC - Ecuador 35
AT - Austria 34
PK - Pakistan 34
CZ - Repubblica Ceca 32
LT - Lituania 32
IE - Irlanda 29
SA - Arabia Saudita 29
FI - Finlandia 28
VE - Venezuela 28
UA - Ucraina 27
MA - Marocco 26
SE - Svezia 26
PH - Filippine 22
JM - Giamaica 20
EG - Egitto 19
UZ - Uzbekistan 19
MY - Malesia 18
CL - Cile 17
AE - Emirati Arabi Uniti 16
PY - Paraguay 14
UY - Uruguay 14
HN - Honduras 13
TH - Thailandia 13
NP - Nepal 12
PE - Perù 12
BO - Bolivia 10
CR - Costa Rica 10
BE - Belgio 9
JO - Giordania 9
RO - Romania 9
CH - Svizzera 8
AU - Australia 7
DZ - Algeria 7
KZ - Kazakistan 7
TN - Tunisia 7
AM - Armenia 6
AZ - Azerbaigian 6
BB - Barbados 6
BG - Bulgaria 6
ET - Etiopia 6
KE - Kenya 6
KW - Kuwait 6
OM - Oman 6
BY - Bielorussia 5
IL - Israele 5
KR - Corea 5
NI - Nicaragua 5
PA - Panama 5
PR - Porto Rico 5
PT - Portogallo 5
SN - Senegal 5
TT - Trinidad e Tobago 5
DO - Repubblica Dominicana 4
GT - Guatemala 4
SC - Seychelles 4
XK - ???statistics.table.value.countryCode.XK??? 4
AL - Albania 3
GA - Gabon 3
GY - Guiana 3
HR - Croazia 3
HU - Ungheria 3
LB - Libano 3
LV - Lettonia 3
LY - Libia 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BZ - Belize 2
CG - Congo 2
EE - Estonia 2
GE - Georgia 2
Totale 20.443
Salva come PNG Salva come JPEG
Città #
Dallas 2.646
San Jose 1.967
Moscow 1.821
Ashburn 716
Singapore 623
The Dalles 370
Abidjan 339
Council Bluffs 334
Lauterbourg 252
New York 204
Hong Kong 188
Beijing 183
Frankfurt am Main 177
Los Angeles 144
Phoenix 133
Ho Chi Minh City 123
Santa Clara 109
São Paulo 83
Hanoi 60
Warsaw 59
Chennai 54
Amsterdam 50
Brooklyn 49
Orem 48
Boardman 47
Denver 45
Nuremberg 43
Montreal 42
Toronto 40
Tokyo 39
Chicago 38
London 37
Milan 37
Assago 30
Boston 30
Munich 30
Johannesburg 28
San Francisco 28
Dublin 27
Atlanta 26
Brno 26
Stockholm 26
Rio de Janeiro 25
Hillsboro 23
Baghdad 22
Mexico City 22
Naples 22
Rome 22
Mumbai 21
Lahore 18
Poplar 18
Tashkent 18
Belo Horizonte 17
Columbus 17
Da Nang 17
Manchester 17
Ankara 16
Brasília 16
Haiphong 15
Houston 15
Buffalo 14
West Jordan 14
Figino 13
Guarulhos 13
Montevideo 13
Ottawa 13
Querétaro 13
Campobasso 12
Charlotte 12
Curitiba 12
Helsinki 12
Jakarta 12
Kingston 12
Guayaquil 11
New Delhi 11
Quito 11
Seattle 11
Volta Redonda 11
Cape Town 10
Caracas 10
Dhaka 10
Falkenstein 10
Goiânia 10
Jeddah 10
Medellín 10
Queens 10
Brussels 9
Casablanca 9
Córdoba 9
Erbil 9
Las Vegas 9
Memphis 9
Vienna 9
Ha Long 8
Kuala Lumpur 8
Lappeenranta 8
Orlando 8
Ribeirão Preto 8
Riyadh 8
Roubaix 8
Totale 12.111
Salva come PNG Salva come JPEG
Nome #
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 622
Metabolic Rewiring of Bacterial Pathogens in Response to Antibiotic Pressure—A Molecular Perspective 547
Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study 176
The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT study 160
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 153
A genic and epigenetic combination therapy for liver cancer 145
Advances in the Insulin–Heart Axis: Current Therapies and Future Directions 143
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 135
A suspected infective endocarditis in patients with a history of chronic HCV infection 133
Angiogenesis inhibitors for the treatment of hepatocellular carcinoma 133
[Inhibitors of intra-cystic secretion: novel therapies in ADPKD (Autosomal Dominant Polycystic Kidney Disease)] 131
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 130
Adherence to AISF recommendations for integrated management of hepatocellular carcinoma in a real–world clinical practice 130
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 129
Advances in Nanomedicine for Precision Insulin Delivery 128
A gene and epigenetic combination therapy for liver cancer treatment 127
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 125
Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis 125
Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights 124
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 123
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 123
. Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics 123
[Next Generation Sequencing and ADPKD] 123
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 122
A Controversial Case of a Double Hepatic Incidentaloma in a Male Patient with Kidney Failure 121
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications 120
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 119
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 118
Antibiotic use and associated factors in a large sample of hospitalised older people 117
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 116
An atypical resentation of a parasitic infection, simulating abdominal expansive mass: a multidisciplinary case report 115
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 115
A clear case of portal hypertension: a logical consequence of liver cirrhosis? 114
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 114
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 111
Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management 110
An atypical presentation of a rare parasitic infection of Fasciola hepatica: a multidisciplinary case report. 110
Adherence to Barcelona Clinic Liver Cancer guidelines in field-practice: results of Progetto Epatocarcinoma Campania 110
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study 109
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 107
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 106
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 105
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 104
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 102
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 100
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 92
Cardiovascular benefits from gliflozins: Effects on endothelial function 90
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 88
Neurophysiological assessment of peripheral neuropathy through whole plantar nerve conduction in type 2 diabetes mellitus and healthy control subjects 88
What changed in the Italian internal medicine and geriatric wards during the lockdown 85
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives 85
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 83
HCV-related steatosis and risk of atherosclerosis 82
Steatosis is a determinant of fibrosis progression in chronic hepatitis C and is correlated both with body composition and viral factors 80
Hepatocellular carcinoma and non alcoholic fatty liver disease; a dangerous liaison 80
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations 79
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 76
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 76
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 76
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 75
Epigenetic and Genetic Keys to Fight HPV-Related Cancers 75
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 75
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 75
Liver fibrosis by FibroScan is highly prevalent in type 2 diabetic patients with NAFLD and fairly normal liver enzymes but increased uric acid 75
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 74
Multidrug-Resistant Infections and Metabolic Syndrome: An Overlooked Bidirectional Relationship 74
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 73
Features of microvessel density (MVD) and angiogenesis inhibitors in therapeutic approach of hepatocellular carcinoma (HCC) 73
Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN Study 72
Cryptogenic cirrhosis is associated with cardiometabolic and oncologic comorbidities and poor liver-related prognosis 72
Sonoporation by microbubbles as gene therapy approach for liver cancer 72
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 71
The importance of the thick ascending limb of Henle's loop in renal physiology and pathophysiology 71
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 70
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 70
Early changes of liver stiffness in HCV patients undergoing treatment with direct-acting antivirals (DDAs): a multicenter study 69
Insulin resistance and cancer: molecular links and clinical perspectives 69
IMPACT OF TYPE II DIABETES ON HCC APPEARANCE IN PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 69
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 69
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 68
Late HCC onset after direct antiviral agents therapy in patients with sustained virological response: do we need to reconsider their efficacy according to long term follow-up? 68
Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects 68
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 67
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 67
Influence of antiviral therapy on liver stiffness evaluation in chronic hepatitis HBV patients in a real world setting: preliminary data in a multicentric study 66
NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes 66
Role of tight glycemic control during acute coronary syndrome on CV outcome in type 2 diabetes 66
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 66
Oncolytic viruses in combination therapeutic approaches with epigenetic modulators: Past, present, and future perspectives 66
Hepatitis C virus eradication by direct antiviral agents improves carotid atherosclerosis in patients with advanced fibrosis/compensated cirrhosis 66
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era? 66
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 66
Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis 65
HCV-related steatosis and risk of atherosclerosis 65
The Role of Lung Ultrasound in SARS-CoV-19 Pneumonia Management 65
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 64
Characteristics and outcome of cryptogenic cirrhosis in Italy 64
Nonalcoholic fatty liver disease: Evolving paradigms 64
Reply to Saeed et al. Comment on “Rinaldi et al. Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study. Viruses 2025, 17, 251” 64
The Intestinal Thread of Fate: How the Microbiota Shapes the Story of Liver Disease 64
Totale 10.437
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.934
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.934
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024334 0 0 0 0 2 151 11 44 5 17 20 84
2024/20253.369 520 223 254 23 416 66 112 121 453 74 490 617
2025/202615.447 530 1.404 1.774 735 3.353 3.104 1.682 639 508 1.157 419 142
2026/20271.373 303 606 464 0 0 0 0 0 0 0 0 0
Totale 20.523